[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  iNewsroom [@iNewsroom](/creator/twitter/iNewsroom) on x 4234 followers Created: 2025-07-16 10:37:51 UTC Johnson & Johnson Q2 2025 Earnings: Adj EPS $XXXX || Sales $23,748, EST, $22.84B) || Stelara Rev $1.65B (est $1.77B) || Darzalex Rev $3.54B (est $3.38B) || Medicine Revenue $15.20B (est $14.52B) || Sees FY Sales $93.2B To 93.6B, Saw $91B To $91.8B || Sees FY Adj Oper EPS… XX engagements  **Related Topics** [$918b](/topic/$918b) [$91b](/topic/$91b) [$932b](/topic/$932b) [$1452b](/topic/$1452b) [$1520b](/topic/$1520b) [$338b](/topic/$338b) [$354b](/topic/$354b) [$177b](/topic/$177b) [Post Link](https://x.com/iNewsroom/status/1945432687637856451)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
iNewsroom @iNewsroom on x 4234 followers
Created: 2025-07-16 10:37:51 UTC
Johnson & Johnson Q2 2025 Earnings: Adj EPS $XXXX || Sales $23,748, EST, $22.84B) || Stelara Rev $1.65B (est $1.77B) || Darzalex Rev $3.54B (est $3.38B) || Medicine Revenue $15.20B (est $14.52B) || Sees FY Sales $93.2B To 93.6B, Saw $91B To $91.8B || Sees FY Adj Oper EPS…
XX engagements
Related Topics $918b $91b $932b $1452b $1520b $338b $354b $177b
/post/tweet::1945432687637856451